Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

Immunotherapy in Early Stage NSCLC and PACIFIC Trial of Durvalumab in Stage III Unresectable NSCLC

504 views
December 19, 2018
0 Comments
Login to view comments. Click here to Login
Lung